Capital Flowing Back into Cannabis Stocks (GWPH, CGC, MCTC, TCNNF)

Cannabis investors have been burnt by oversupply and a proliferation of pretenders over the past two years. But the sun is finally starting to come back out from behind those clouds over the past month, with many survivors starting to show signs of thriving in the post-purge world that now defines the space. The pandemic […]

Why the Bottom is in for Pot Stocks ($TLRY, $NUGS, $APHA, $GTBIF, $CURLF)

After a torturous bear market, the bottom may finally be in place for the cannabis sector. Why? There are three big reasons. First, cannabis has become a seasonal marketplace. The price of cannabis flower will likely be on the rise as the dry season comes to an end and outdoor producers wind down their inventories […]

Nasdaq Considering Launching Its Own Cryptocurrency Exchange But Must Consider Regulations

Nasdaq has been keeping a close eye on events in the digital currency industry. Nasdaq CEO Adena Friedman now says the company may consider running its own cryptocurrency in the future. The wave of digital currency has been sweeping around the world and has attracted the attention of financial regulators and governments alike. It may […]

Catalyst Biosciences Inc (NASDAQ:CBIO) Announces Helpful Factor IX Clinical Data

Catalyst Biosciences Inc (NASDAQ:CBIO) announced recently that they have successfully achieved the positive clinical data from its ongoing Phase 1/2 clinical data in the participants with severe hemophilia B condition. The team was excited by the results that showed the higher potency and advanced pharmacokinetics of CB 2679d. The findings have numerous advantages over the […]

ImmunoGen, Inc. (NASDAQ:IMGN) and Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) Collaborates To Build ADC Molecule

ImmunoGen, Inc. (NASDAQ:IMGN) announced recently that they are entering into a partnership and option agreement with Jazz Pharmaceuticals plc –Ordinary Shares (NASDAQ:JAZZ) to develop and commercialize the stage two, hematology-related Antibody-Drug Conjugate (ADC) programs in addition to another program that will be authorized within the terms of agreement. The programs will cover the IMGN779- CD33-targeting […]

Delcath Systems, Inc. (NASDAQ:DCTH) Closes In Green

In the last trading session, the stock price of Delcath Systems, Inc. (NASDAQ:DCTH) jumped more than 17% to close the day at $0.122. After the recent gains, the market cap of firm now stands at $60.63 million. More recently, the company congratulated the team at the renowned Medical University of Hannover Hospital on their exception […]

The Preclinical Influenza Nanoparticle Study By Novavax, Inc (NASDAQ:NVAX) Published In Vaccine

The stock of Novavax, Inc (NASDAQ:NVAX) closed at $1.06 maintaining the same standing in yesterday’s trading session. This provider has today made an announcement regarding the publication of data from a preclinical study of its nanoparticle influenza vaccine candidate with its proprietary Matrix-M(TM) adjuvant (NanoFlu(TM)) in the journal Vaccine. It is directing a lot of […]

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Appoints New Chief Financial Officer

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) announced recently that it has augmented its executive management team with the addition of Jean M. Franchi as the new Chief Financial Officer (CFO) effective August 21, 2017. Ms. Franchi will take up the role of planning and overseeing the overall financial activities of the company to significantly support the continuous […]

CytRx Corporation (NASDAQ:CYTR) Plans To Avoid Delisting From NASDAQ

CytRx Corporation (NASDAQ:CYTR) reported that it has submitted a preliminary proxy statement with the SEC pertaining to a planned special meeting of shareholders to authorize the company’s Board to follow a reverse stock split of the firm’s common stock, if seen necessary. It may allow the firm to regain compliance with NASDAQ’s $1 minimum bid […]

Tandem Diabetes Care Inc (NASDAQ:TNDM) Begins Enrollment In Pivotal Trial For First Touchscreen Insulin Pump With Predictive Low Glucose Suspend (PLGS)

Tandem Diabetes Care Inc (NASDAQ:TNDM) has announced that it has enrolled its first patient in its trial for its t:slim X2™ Insulin Pump using the company’s predictive low glucose suspend (PLGS) technology. Tandem Diabetes Care is engaged in the manufacture of medical devices as well as touchscreen insulin pumps which are supplied in the United […]

MannKind Corporation (NASDAQ:MNKD) And One Drop To Strike A Collaboration To Help Diabetes Patients

MannKind Corporation (NASDAQ:MNKD) made an announcement about its collaboration with One drop revealing that they were going to engage in a randomized controlled trial. This will be in a bid to investigate the use of Afrezza inhaled insulin. One Drop’s integrated digital diabetes care platform will also be scrutinized further in an effort to identify the […]

What Is The Buzz Surrounding Amarin Corporation plc (ADR)(NASDAQ:AMRN)?

Amarin Corporation plc (ADR)(NASDAQ:AMRN) reported that the data monitoring committee has completed its assessment of the planned pre-specified interim safety and efficacy evaluation for the REDUCE-IT cardiovascular outcomes trial and has recommended that the study continue as planned without any changes. The details As REDUCE-IT is the preliminary prospective clinical study of any treatment in […]

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief Business Officer

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) reported that the company has appointed Gregory Naeve, Ph.D., as Chief Business Officer. Dr. Naeve will lead portfolio and product strategy and business development for the firm. The details Rick Fair, the CEO and President of Bellicum, reported that they are thrilled to welcome a leader of Dr. Naeve’s caliber and […]